Noninvasive vagus nerve stimulation may be a viable method for the treatment of acute episodic migraine, according to a new study.
Headache and Migraine
The first CGRP mAb has been FDA-approved, but why should you consider this novel category for migraine prevention?
Menstrual migraine can be a tricky diagnosis. Test your knowledge of the headaches and gather clinical tips with our 8-question quiz.
Take a closer look at how erenumab, the first CGRP inhibitor to win FDA-approval for migraine prevention, earned that spot.
How much do you know about migraine/severe headache in the US? Take our 10-question quiz to find out.
Results from a recent analysis of trends in US migraine prevalence show disease burden higher in populations that may be neglected. Are any of your patients at risk?
Drugs that treat migraine come from a variety of classes and reflect on- and off-label use. How current are you?
Neurostimulators are an emerging treatment option for migraine patients who want non-pharmacologic treatment. Find out what you know about the three devices approved for use in the US.
In the largest study to date of blockade of the greater occipital nerve for migraine treatment, more than half of patients claimed a 50% reduction in pain.
One of my migraine patients taught me that I need to ask the very hard questions if I want to offer the best possible care.